English(EN) Chinese stem cell therapy reverses heart failure in 90% of patients in landmark trial

中国干细胞疗法在心力衰竭试验中显示90%的康复率

作者 PulseAugur 编辑部 · [1 个来源] · 2026-08-20 14:00

中国的一项临床试验显示，一种旨在治疗严重心力衰竭的新型干细胞疗法取得了可喜的成果。南京大学附属南京鼓楼医院的研究人员报告称，在接受诱导多能干细胞（iPSC）衍生的心肌细胞注射12个月后，90%的患者心功能显著恢复。该疗法为心脏移植提供了一种潜在的替代方案，而心脏移植受限于供体器官的稀缺性。 AI

影响这项研究可能带来治疗心脏病的新型再生医学疗法，从而可能减少对器官移植的依赖。

排序理由该集群报告了一项发表在科学期刊上的II期临床研究结果，详细介绍了新型疗法的有效性。[lever_c_demoted from research: ic=1 ai=0.4]

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 0 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; 该集群报告了一项发表在科学期刊上的II期临床研究结果，详细介绍了新型疗法的有效性。[lever_c_demoted from research: ic=1 ai=0.4]
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: paper, product; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: Standard; On-topic for AI-industry coverage; kept in the public index.
Story freshness: 49 days old; Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。

SCMP — Tech TIER_1 English(EN) · Shi Huang · 2026-08-20 14:00

中国干细胞疗法在里程碑式试验中使90%的患者心力衰竭逆转

A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel therapy. On Wednesday, Nanjing Drum Tower Hospital, affiliated with Nanjing University, released th…